tiprankstipranks
Trending News
More News >
Sino Biopharmaceutical Ltd (DE:SMZ1)
FRANKFURT:SMZ1
Germany Market
Advertisement

Sino Biopharmaceutical (SMZ1) Ratios

Compare
0 Followers

Sino Biopharmaceutical Ratios

DE:SMZ1's free cash flow for Q2 2025 was ¥0.82. For the 2025 fiscal year, DE:SMZ1's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.36 1.05 1.29 1.53 2.08
Quick Ratio
1.28 0.96 1.17 1.41 1.91
Cash Ratio
0.45 0.42 0.43 0.63 0.97
Solvency Ratio
0.17 0.13 0.23 0.68 0.24
Operating Cash Flow Ratio
0.13 0.27 0.31 0.35 0.49
Short-Term Operating Cash Flow Coverage
0.36 0.54 0.64 0.81 3.43
Net Current Asset Value
¥ 4.70B¥ -1.63B¥ -185.83M¥ 688.86M¥ -2.00B
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.20 0.22 0.20 0.30
Debt-to-Equity Ratio
0.36 0.41 0.47 0.40 0.85
Debt-to-Capital Ratio
0.26 0.29 0.32 0.29 0.46
Long-Term Debt-to-Capital Ratio
0.08 0.03 0.12 0.15 0.42
Financial Leverage Ratio
2.24 2.09 2.15 2.00 2.82
Debt Service Coverage Ratio
0.62 0.53 0.58 2.57 3.13
Interest Coverage Ratio
0.00 11.68 15.24 61.11 15.12
Debt to Market Cap
0.11 0.17 0.18 0.14 0.12
Interest Debt Per Share
0.66 0.56 0.77 0.66 0.77
Net Debt to EBITDA
0.14 0.45 0.80 0.13 0.55
Profitability Margins
Gross Profit Margin
81.77%80.95%79.86%80.15%78.08%
EBIT Margin
16.71%22.54%19.61%70.29%22.57%
EBITDA Margin
20.00%26.64%23.25%73.99%27.67%
Operating Profit Margin
20.12%22.08%23.25%70.21%20.67%
Pretax Profit Margin
24.96%20.65%20.08%69.14%21.20%
Net Profit Margin
12.67%8.90%17.38%54.38%18.36%
Continuous Operations Profit Margin
22.15%17.61%15.70%61.85%18.36%
Net Income Per EBT
50.73%43.10%86.57%78.66%86.59%
EBT Per EBIT
124.09%93.50%86.37%98.47%102.55%
Return on Assets (ROA)
5.17%3.67%7.81%24.13%9.19%
Return on Equity (ROE)
11.85%7.65%16.82%48.23%25.92%
Return on Capital Employed (ROCE)
12.29%14.11%15.24%41.73%13.48%
Return on Invested Capital (ROIC)
9.59%9.45%10.77%32.50%11.18%
Return on Tangible Assets
5.39%3.72%8.05%24.83%9.65%
Earnings Yield
3.42%3.28%6.66%17.50%3.66%
Efficiency Ratios
Receivables Turnover
3.69 5.70 6.20 6.27 8.11
Payables Turnover
1.98 3.74 3.08 2.97 2.66
Inventory Turnover
2.65 2.50 2.49 2.75 2.76
Fixed Asset Turnover
3.04 2.64 3.11 3.15 3.30
Asset Turnover
0.41 0.41 0.45 0.44 0.50
Working Capital Turnover Ratio
3.41 7.50 4.13 2.68 1.65
Cash Conversion Cycle
52.03 112.22 86.92 68.02 40.21
Days of Sales Outstanding
98.95 64.03 58.89 58.23 44.98
Days of Inventory Outstanding
137.80 145.82 146.67 132.64 132.42
Days of Payables Outstanding
184.73 97.63 118.64 122.85 137.19
Operating Cycle
236.75 209.85 205.56 190.87 177.39
Cash Flow Ratios
Operating Cash Flow Per Share
0.18 0.26 0.34 0.29 0.28
Free Cash Flow Per Share
0.16 0.19 0.24 0.19 0.18
CapEx Per Share
0.02 0.07 0.09 0.10 0.10
Free Cash Flow to Operating Cash Flow
0.91 0.72 0.73 0.65 0.65
Dividend Paid and CapEx Coverage Ratio
11.67 2.60 2.11 1.89 1.75
Capital Expenditure Coverage Ratio
11.67 3.56 3.67 2.83 2.86
Operating Cash Flow Coverage Ratio
0.26 0.48 0.45 0.44 0.37
Operating Cash Flow to Sales Ratio
0.10 0.23 0.22 0.20 0.23
Free Cash Flow Yield
2.57%6.14%6.07%4.16%2.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.25 30.45 15.02 5.71 27.33
Price-to-Sales (P/S) Ratio
3.68 2.71 2.61 3.11 5.02
Price-to-Book (P/B) Ratio
3.39 2.33 2.53 2.76 7.08
Price-to-Free Cash Flow (P/FCF) Ratio
38.89 16.28 16.48 24.04 34.22
Price-to-Operating Cash Flow Ratio
35.83 11.71 11.99 15.55 22.28
Price-to-Earnings Growth (PEG) Ratio
0.78 -0.43 -0.23 0.02 -3.42
Price-to-Fair Value
3.39 2.33 2.53 2.76 7.08
Enterprise Value Multiple
18.52 10.62 12.03 4.33 18.68
Enterprise Value
113.22B 74.13B 80.47B 85.98B 122.21B
EV to EBITDA
18.52 10.62 12.03 4.33 18.68
EV to Sales
3.70 2.83 2.80 3.20 5.17
EV to Free Cash Flow
39.18 17.00 17.65 24.76 35.26
EV to Operating Cash Flow
35.82 12.22 12.84 16.02 22.95
Tangible Book Value Per Share
2.37 1.59 1.93 1.92 1.07
Shareholders’ Equity Per Share
1.85 1.30 1.60 1.61 0.89
Tax and Other Ratios
Effective Tax Rate
0.08 0.15 0.13 0.11 0.13
Revenue Per Share
1.70 1.12 1.55 1.43 1.26
Net Income Per Share
0.21 0.10 0.27 0.78 0.23
Tax Burden
0.51 0.43 0.87 0.79 0.87
Interest Burden
1.49 0.92 1.02 0.98 0.94
Research & Development to Revenue
0.19 0.17 0.15 0.14 0.11
SG&A to Revenue
0.07 0.07 0.08 0.08 0.11
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.00 0.00
Income Quality
0.82 1.02 1.08 0.29 1.06
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis